Full Schedule

Lead Speaker: Jacqueline G. Hugtenburg – University of Curacao and VU University Medical Center Amsterdam

Speaker: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Speaker: Robert Gross, MD, MSCE, FISPE – University of Pennsylvania

Lead Speaker: Petra Denig, PharmD, PhD, FISPE – University Medical Center Groningen

Speaker: Katja Taxis, MSc, PhD, FISPE – University of Groningen

Speaker: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto

Speaker: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet

Lead Speaker: Nivantha Naidoo, MBChB, DipPEC, MPH, MSc CER (she/her/hers) – Cerner Enviza an Oracle company

Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited

Speaker: Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit

Speaker: Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc.

Lead Speaker: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA

Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion

Speaker: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA

Speaker: Elizabeth M. Garry, MPH, PhD – Aetion, Inc.

Lead Speaker: Geetha Iyer, MBBS, SM, PhD – Harvard School of Public Health

Speaker: Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson

Lead Speaker: Harriet Dickinson, MPhil, PhD – Gilead

Lead Speaker: Dana Y. Teltsch, PhD, MSc – Takeda

Speaker: Victoria Y. Strauss, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG

Speaker: Orla M. Doyle, PhD, BEng – Novartis

Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA

Lead Speaker: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration

Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA

Speaker: Mackenzie M. Herzog, PhD, MPH (she/her/hers) – IQVIA

Speaker: David Maislin – Biomedical Statistical Consulting

Speaker: Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson

Lead Speaker: Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC

Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA

Speaker: William G. Dixon, MD PhD – The University of Manchester

Speaker: Nabarun Dasgupta, MPH, PhD – UNC Injury Prevention Research Center, University of North Carolina, Chapel Hill, NC, USA

Lead Speaker: Miguel A. Hernan – CAUSALab, Harvard T.H. Chan School of Public Health

Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited

Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions

Lead Speaker: Jaclyn L. Bosco, PhD, MPH. FISPE – IQVIA

Speaker: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.

Speaker: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona

Speaker: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration

Lead Speaker: Jennifer Gerber, PhD, MSc – GlaxoSmithKline

Speaker: Morgan Marks, PhD (he/him/his) – Infectious Disease Epidemiology, Moderna Therapeutics Inc.

Speaker: Henok Tadesse Ayele, PhD – Merck & Co., Inc.

Speaker: Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA

Speaker: Robert T. Chen, MA, MD, FISPE – Brighton Collaboration

Speaker: Joanne Wu, ScD (she/her/hers) – Pfizer Inc

Speaker: Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc

Speaker: Deshayne B. Fell – University of Ottawa

Speaker: Annette Regan, PhD, MPH (she/her/hers) – University of San Francisco, San Francisco CA, USA

Speaker: Leah J. McGrath, PhD – Pfizer

Speaker: Christopher G. Prener, PhD – Pfizer, Inc

Lead Speaker: Andrea V. Margulis, MD ScD FISPE – RTI Health Solutions

Speaker: Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine

Speaker: Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University

Speaker: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School

Lead Speaker: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School

Speaker: Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania

Speaker: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité

Lead Speaker: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School

Lead Speaker: Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration

Speaker: G. Niklas Norén, PhD – Uppsala Monitoring Centre

Speaker: Greg Powell, PharmD, MBA (he/him/his) – GlaxoSmithKline

Lead Speaker: Priya Bahri, PhD, PGDipEpi, RPh, FISoP – European Medicines Agency

Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc

Speaker: Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board

Speaker: Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago

Speaker: Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson

Speaker: Rania Mouchantaf, PhD (she/her/hers) – Health Canada

Speaker: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety